We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+7.63%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.77B
AUM Growth
+$83.3M
Cap. Flow
-$75.7M
Cap. Flow %
-1.59%
Top 10 Hldgs %
8.04%
Holding
1,297
New
101
Increased
425
Reduced
422
Closed
77

Top Buys

Rank Stock Value
1
PTEN icon
Patterson-UTI
PTEN
+$16M
2
CNXC icon
Concentrix
CNXC
+$14M
3
BUR icon
Burford Capital
BUR
+$12.4M
4
XPRO icon
Expro Ltd
XPRO
+$12.4M
5
PRGO icon
Perrigo
PRGO
+$11M

Top Sells

Rank Stock Value
1
HCC icon
Warrior Met Coal
HCC
+$23M
2
PINC
Premier
PINC
+$19.3M
3
TDS icon
Telephone and Data Systems
TDS
+$16.7M
4
TTMI icon
TTM Technologies
TTMI
+$11.8M
5
INDB icon
Independent Bank
INDB
+$11.1M

Sector Composition

Rank Sector Weight
1 Financials 28.75%
2 Consumer Discretionary 13.52%
3 Technology 11.88%
4 Industrials 10.57%
5 Energy 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRUE
851
DELISTED
TrueCar
TRUE
$431K 0.01%
190,820
+55,000
+40% +$118K
SLP icon
852
Simulations Plus
SLP
$371M
$428K 0.01%
+23,500
New +$412K
NAGE
853
Niagen Bioscience
NAGE
$247M
$427K 0.01%
67,179
-25,000
-27% -$174K
SLDP icon
854
Solid Power
SLDP
$532M
$425K 0.01%
100,000
-50,000
-33% -$276K
LRMR icon
855
Larimar Therapeutics
LRMR
$432M
$424K 0.01%
111,216
+33,000
+42% +$128K
AZZ icon
856
AZZ Inc
AZZ
$4.54B
$423K 0.01%
3,949
– –
BDTX icon
857
Black Diamond Therapeutics
BDTX
$112M
$421K 0.01%
173,300
+75,000
+76% +$266K
AQST icon
858
Aquestive Therapeutics
AQST
$494M
$419K 0.01%
64,900
-2,800
-4% -$17.4K
FNWB icon
859
First Northwest Bancorp
FNWB
$104M
$418K 0.01%
44,608
+5,441
+14% +$49.5K
KWY
860
Kingsway Corp
KWY
$293M
$418K 0.01%
31,100
– –
TRDA icon
861
Entrada Therapeutics
TRDA
$267M
$411K 0.01%
40,000
– –
PEPG icon
862
PepGen
PEPG
$197M
$410K 0.01%
63,000
– –
JILL icon
863
J. Jill
JILL
$283M
$408K 0.01%
29,759
+12,959
+77% +$196K
RCEL icon
864
Avita Medical
RCEL
$239M
$407K 0.01%
118,004
– –
PETS icon
865
PetMed Express
PETS
$42.3M
$404K 0.01%
126,351
+18,535
+17% +$46.5K
FHTX icon
866
Foghorn Therapeutics
FHTX
$360M
$403K 0.01%
74,600
– –
NMRA icon
867
Neumora Therapeutics
NMRA
$302M
$403K 0.01%
225,000
– –
HAIN icon
868
Hain Celestial
HAIN
$53.7M
$396K 0.01%
369,735
+15,392
+4% +$19K
BVFL icon
869
BV Financial
BVFL
$186M
$394K 0.01%
21,747
+1,983
+10% +$34.1K
PLRX icon
870
Pliant Therapeutics
PLRX
$65M
$392K 0.01%
321,530
+239,230
+291% +$359K
UAMY icon
871
United States Antimony
UAMY
$1.02B
$391K 0.01%
77,800
– –
CVRX icon
872
CVRx
CVRX
$63.4M
$383K 0.01%
54,000
– –
AMWL icon
873
American Well
AMWL
$230M
$383K 0.01%
77,989
– –
AEI icon
874
Alset
AEI
$45.9M
$383K 0.01%
111,254
+10,946
+11% +$29.5K
ATLO icon
875
AMES National
ATLO
$277M
$382K 0.01%
16,647
+642
+4% +$13.8K
33 34
35
36 37

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Bridgeway Capital Management held 1,297 positions worth $4.77B, up 1.8% from $4.69B the previous quarter. Its ten largest holdings account for 8% of the portfolio.

Bridgeway Capital Management's Q4 2025 filing shows 101 new, 425 increased, 422 reduced and 77 closed positions. Its largest new stake was Patterson-UTI: 2,679,554 shares worth $16.4M. The largest sale was Warrior Met Coal, an estimated $23M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bridgeway Capital Management's largest Q4 2025 buy was Patterson-UTI: 2,679,554 shares worth $16.4M.
  • Bridgeway Capital Management added most to Trustmark in Q4 2025, an estimated $9.24M increase.
  • Bridgeway Capital Management's biggest Q4 2025 reduction was Warrior Met Coal, cutting an estimated $23M.
  • Bridgeway Capital Management fully exited Premier in Q4 2025, selling an estimated $19.3M.
  • Bridgeway Capital Management's ten largest holdings make up 8% of its $4.77B portfolio in Q4 2025.
  • Bridgeway Capital Management opened 101 new positions and closed 77 in Q4 2025.
  • Bridgeway Capital Management's portfolio value rose 1.8% quarter-over-quarter to $4.77B.

Based on Bridgeway Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.